Genetic Testing for Breast Cancer Risk

Practice evaluating how well a particular genetic test assesses breast cancer risk and the potential impact of testing on patient outcomes.


About This Course

ribbon graphicThere are numerous options for breast cancer genetic testing, with different strengths and limitations depending on the patient’s personal and family history. In this course you will practice evaluating how well a particular genetic test assesses breast cancer risk (clinical validity) and the potential impact of testing on patient outcomes (clinical utility). This course is targeted to clinicians who order breast cancer genetic testing.

 ACCESS CME MODULE   ACCESS CNE MODULE 

 

This course is part of the Cancer Genetic Clinical Education program.


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Connecticut School of Medicine and The Jackson Laboratory. The University of Connecticut School of Medicine is accredited by the ACCME to provide continuing medical education for physicians. The University of Connecticut School of Medicine designates the enduring material for a maximum of .25 AMA PRA Category 1 Credit(s)™ (per module). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This continuing nursing education activity was approved by the Northeast Multi-State Division (NE-MSD), an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.


This course is part of the Genetics Risk Assessment Cancer Education program.
This course is part of the Genetics Risk Assessment Cancer Education program.